Publications

Torres C, Kramer A, Racz L, Vivanco S, Panko J. Anticipating number of days that exceed OSHA proposed heat triggers. Abstract 1501, Poster Session 3, AIHA Connect 2026, New Orleans, LA, June 3, 2026.

Kramer M, Torres CV. Feasibility assessment of EPA’s OEVs/ECELs. Research Roundup Presentation C1b, AIHA Connect 2026, New Orleans, LA, June 1, 2026.

Haws L (Moderator), Maxwell G (Speaker), Kleinstreuer N, Lowit A, Harrill J (Panelists). Next generation risk assessment (NGRA): Emerging best practice & opportunities for regulatory use. Society of Toxicology Risk Assessment Specialty Section (RASS) Risk Assessment Syllabus Webinar, June 17, 2026.

Kennedy SB, Heintz MM, Brown L, Fender CL, Hecker M, Hughes SA, Naile J, DeLeo P. Defining the domain of applicability: A case study to increase confidence in toxicogenomic tools for ecological risk assessment. Poster 1.03.P-Tu032, SETAC Europe 36^th Annual Meeting, Maastricht, The Netherlands, May 19, 2026.

Wigh A, Campos B, de Croze N, Roush K, Suzuki T, Brown L, Kennedy SB, Hecker M, et al. Chronic fish toxicity case studies toward a best practice guidance document. Poster 1.09P-Mo042, SETAC Europe 36^th Annual Meeting, Maastricht, The Netherlands, May 18, 2026.

Rethlefsen ML, Brigham TJ, Price C, Reynolds JM. From brie-f comments to lasting revisions: Librarian peer review in action. Research paper presentation, Annual Meeting of the Medical Library Association, Milwaukee, WI, May 2026. Awarded 2^nd Place Paper by research awards judging team.

Nordyke RJ, Cyr P, Jensen I. Gene therapy development programs are both growing and evolving in the face of commercial headwinds. Poster Session 3/No. HPR71, ISPOR 2026, Philadelphia, PA, May 19, 2026.

Nordyke RJ, Jensen I, Hooda N, Miller B. Rising levels of innovation in expedited designations among FDA-approved drugs: 2012-2024. Poster Session 2/No. HPR63, ISPOR 2026, Philadelphia, PA, May 18, 2026.

Fitch S, Lozy F, Mitchell C, Patlewicz G, Wood A. Use of new approach methodologies in the safety assessment of dietary supplements—Parts one and two. Webinar series, Council for Responsible Nutrition (CRN), Washington, DC, May 2026.

Doepker C, Franzen A, Brorby G*, Wikoff D, Thompson C. From alerts to evidence: Advancing the use of in vivo genotoxicity dose-response data for complex mixtures. Poster/Abstract PA3, International Conference on the Science of Botanicals (ICSB), Oxford, MS, April 2026. (*poster only)

Pokorney S, Hooda N, Jiang X, Liu Y, Sacks N, Sheikh M, Bharucha D, Desai N. Healthcare resource use and expenditures among adults with paroxysmal supraventricular tachycardia in the United States. Poster presentation, Poster Abstract 44, Academy of Managed Care Pharmacy National Meeting—AMCP 2026, Nashville, TN. J Manag Care Spec Pharm 32(4-a):S15-S16, April 13-26, 2026.

Moriarty C, Smith M, Hagerty M, Smith S, Garman B, Cherry J, Jacobellis M, et al. PFOS and PFOA alter mitochondrial metabolism in myoblasts. Poster presented at Carolina Society of Environmental Toxicology and Chemistry, North Carolina State University, Raleigh, NC, 2026.

Jacobellis M, Garcia M, Bain L, Pearce J, Hunt K, Baldwin W. Disruption of energy homeostasis by chemical mixtures containing persistent pollutants in HepG2 and C2C12 cells. Platform presentation, Carolina Society of Environmental Toxicology and Chemistry, North Carolina State University, Raleigh, North Carolina, 2026.

Wikoff D, Brown L. Development of an integrated human and environmental health safety assessment framework: Initial findings and progress from a consortium effort. Abstract 1050, Society of Toxicology 65^th Annual Meeting, San Diego, CA, March 2026.

Wikoff D, Fitch S, Eichenbaum G, Ejaz S, Klaren W, Southall M. Need for fit-for-purpose approaches that integrate dose, mechanism, and context of use with key characteristics when evaluating the carcinogenic potential of widely used therapeutics: A case study of acetaminophen. Abstract 4005, Society of Toxicology 65^th Annual Meeting, San Diego, CA, March 2026.

Vincent M, Wheeler M, Schaefer H, Rhoden J, Fitch S, Wikoff D. Quantitative bias assessment to facilitate assessment of (un)certainty in observational data evaluating acetaminophen use and liver cancer. Abstract 4279, Society of Toxicology 65^th Annual Meeting, San Diego, CA, March 2026.

Shobair M, Allen D, Ballone I, Brull M, Burbank M, Choksi N, Fitch S, Irizar A, et al. A machine-learning approach for the development of a knowledgebase to identify systemic toxicity mechanistic targets and evaluate biological space coverage. Abstract 5161, Society of Toxicology 65^th Annual Meeting, San Diego, CA, March 2026.

Proctor DM, Verwiel AH, Covington TR, Thompson CM. Acute (24-hour) nickel inhalation reference concentration for use in air toxics risk assessment. Abstract 3997, Society of Toxicology 65^th Annual Meeting, San Diego, CA, March 2026.

Price SA, Bare JL, Verwiel AH, Proctor DM. Novel application of the EPA All Ages Lead Model (AALM) to determine an acute (24-hour) inhalation threshold for lead protective of neurotoxicity in children. Abstract 4604, Society of Toxicology 65^th Annual Meeting, San Diego, CA, March 2026.

Patlewicz G, Mihalchik A, Thompson CM, East A, Borghoff S. Investigating the feasibility of deriving a new environmentally relevant Thresholds of Toxicological Concern (TTCs) from estimated human equivalent benchmark dose (eBMD_HED) values. Abstract 4013, Society of Toxicology 65^th Annual Meeting, San Diego, CA, March 2026.